HeartBeam Inc. Recognized with 2025 Innovation Award for Breakthrough in Remote Cardiac Diagnostics

HeartBeam Inc. (NASDAQ: BEAT), a leader in medical technology focused on revolutionizing cardiac care, has been honored with the 2025 Innovation Award in Remote Cardiac Diagnostics by the Medical Device Network Excellence Awards. This recognition underscores the company's pioneering 3D ECG technology, which facilitates clinical-grade arrhythmia diagnostics outside traditional medical settings through a compact, cable-free device. Currently, HeartBeam's synthesized 12-lead ECG software is undergoing FDA review, with plans to commercialize the technology upon receiving clearance. This accolade further cements HeartBeam's position at the forefront of remote cardiac care innovation.

The award highlights the potential of HeartBeam's technology to transform cardiac diagnostics by enabling accurate heart monitoring in non-clinical environments. This advancement could significantly improve patient outcomes by allowing for early detection and intervention of cardiac conditions, thereby reducing the need for hospital visits. For more details on HeartBeam's achievement, visit https://ibn.fm/vEL8J.